These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26982203)

  • 21. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
    Zwerina J; Tuerk B; Redlich K; Smolen JS; Schett G
    Arthritis Res Ther; 2006; 8(1):R22. PubMed ID: 16507121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
    Liu Q; Zhao J; Tan R; Zhou H; Lin Z; Zheng M; Romas E; Xu J; Sims NA
    Scand J Rheumatol; 2015 May; 44(3):182-91. PubMed ID: 25439190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein-3 is a negative regulator of bone density.
    Daluiski A; Engstrand T; Bahamonde ME; Gamer LW; Agius E; Stevenson SL; Cox K; Rosen V; Lyons KM
    Nat Genet; 2001 Jan; 27(1):84-8. PubMed ID: 11138004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatory responses of proinflamamtory cytokines on nitric oxide-mediated function in mouse calvarial osteoblasts.
    Park YG; Kim KW; Song KH; Lee JM; Hong JJ; Moon SK; Kim CH
    Cell Biol Int; 2009 Jan; 33(1):92-9. PubMed ID: 18957328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor Protein Tyrosine Phosphatase α-Mediated Enhancement of Rheumatoid Synovial Fibroblast Signaling and Promotion of Arthritis in Mice.
    Stanford SM; Svensson MN; Sacchetti C; Pilo CA; Wu DJ; Kiosses WB; Hellvard A; Bergum B; Muench GR; Elly C; Liu YC; den Hertog J; Elson A; Sap J; Mydel P; Boyle DL; Corr M; Firestein GS; Bottini N
    Arthritis Rheumatol; 2016 Feb; 68(2):359-69. PubMed ID: 26414708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
    Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
    Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
    Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
    J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.
    Daans M; Lories RJ; Luyten FP
    Arthritis Res Ther; 2008; 10(5):R115. PubMed ID: 18816401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
    Redlich K; Görtz B; Hayer S; Zwerina J; Doerr N; Kostenuik P; Bergmeister H; Kollias G; Steiner G; Smolen JS; Schett G
    Am J Pathol; 2004 Feb; 164(2):543-55. PubMed ID: 14742260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The aryl hydrocarbon receptor suppresses osteoblast proliferation and differentiation through the activation of the ERK signaling pathway.
    Yu H; Du Y; Zhang X; Sun Y; Li S; Dou Y; Li Z; Yuan H; Zhao W
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):502-10. PubMed ID: 25194622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
    Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
    Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.
    Ding J; Ghali O; Lencel P; Broux O; Chauveau C; Devedjian JC; Hardouin P; Magne D
    Life Sci; 2009 Apr; 84(15-16):499-504. PubMed ID: 19302812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Wang G; Dunstan CR; Zreiqat H
    Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP3: to be or not to be a BMP.
    Bahamonde ME; Lyons KM
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S56-62. PubMed ID: 11263666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-linked N-acetylglucosamine glycosylation of p65 aggravated the inflammation in both fibroblast-like synoviocytes stimulated by tumor necrosis factor-α and mice with collagen induced arthritis.
    Kim HB; Lee SW; Mun CH; Yoon JY; Pai J; Shin I; Park YB; Lee SK; Cho JW
    Arthritis Res Ther; 2015 Sep; 17(1):248. PubMed ID: 26370562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.